About Cerebrum Matter

The idea of creating Cerebrum Matter stems from our founder’s personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago. Bojan’s vision to treat early onset dementia through digital therapy has been transformed into Cerebrum Matter’s mission to reduce the prevalence of disabling symptoms for people living with dementia.

Our idea of digital healthcare came to the fore in 2016 when the company’s bootstrapping stage, leading to the idea of a therapy software highly focused on Mental well-being. The development of the software tunnelled into the R&D process by end of 2017, leading us to start working on conducting a clinical trial with people to develop an evidence-based product aiming sincerely at treating cognitive declination, depression, anger & anxiety, the logical reasoning which are considered to leading onset symptoms of dementia using brainwave analysis.

Changing the Game for Healthy Ageing

Dementia is the broad category of neurodegenerative brain diseases that includes such diseases as Alzheimer’s, vascular dementia and Lewy body dementia, etc. In the case of most progressive dementias, including Alzheimer’s disease, there is no cure and no treatment that slows or stops its progression. But there are drug treatments that may temporarily improve symptoms but of high risk prescribing them at early stages, which is not in practice.

While the use of medication is undoubtedly vital in helping both severe and light sufferers of dementia, Cerebrum Matter believes that dementia prevention is still an underdeveloped form of treatment that could potentially change the way the earlier stages of dementia are treated; if rights products and innovation are applied. While the ‘brain training’ software market is relatively crowded, Cerebrum Matter will have a clinically validated product classified as a medical device, and also with our developing advanced brainwave technology we are aiming to provide a personalised experience of cognitive improvement according to each individuals’ brain functionalities.


To prevent and reduce the prevalence of the symptoms of early onset dementia, by promoting mental wellness and thus leading to longer and higher quality independent lives to the elderly.


To become a Global leader in the field of cognitive therapy focused brainwave technology, leading to a significant reduction in the estimated numbers of future potential victims of dementia.


We wouldn’t be able to take Cerebrum Matter to the next level without our incredible team of entrepreneurs who collaborate together to make each project come to life. Our research team runs like a well-oiled machine, developing our innovative products aimed at making people lives better.



Miss Kartheka Bojan, Founder & CEO of Cerebrum Matter Ltd, a digital healthcare start-up working on early dementia. She holds an MSc in Biomedical Engineering from the University of Nottingham. After working at IBM India, she spent 5 years in the UK developing medical devices.
She is the author of pending patents in EEG technology for Alzheimer’s & a Glucose Monitoring device and has also published work on Design of Biosensors with Gold Nanoparticles.Her innovative technical and business skills have been recognized with awards from NASA, IEEE and Nottingham & Leicester Universities.


Director of Clinical Research

Prof.Elizabeta is chairman of Old Age Psychiatry, Leicester University and Clinical Lead for Validating the COSMA Software with early demented patients and responsible for clinical R&D of the project. Her areas of academic interest include developing biomarkers with high sensitivity and specificity to detect various forms of dementia, and their implementation in routine clinical setting with an aim to monitor the progression of the disease and treatment.


University of Leicester

Clinical Partner


Chinese National Healthy Living Centre

Market Partner